Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Wechsler

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Seizure|June 21, 2020
Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsyChristian Brandt, Robert T Wechsler, Terence J O'Brien, et al.
Epilepsia Open|April 21, 2022
Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsyJacqueline A French, Robert T Wechsler, Eugen Trinka, et al.
Epilepsia Open|July 15, 2024
Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complexRobert T Wechsler, David E Burdette, Barry E Gidal, et al.
Epilepsy Research|June 4, 2014
Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsyRobert T Wechsler, Robert Leroy, Anne Van Cott, et al.
Epilepsia|July 10, 2020
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studiesIvan Rektor, Gregory L Krauss, Yushi Inoue, et al.
Epilepsia|September 2, 2016
Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizuresRobert C Sergott, Chris A Johnson, Kenneth D Laxer, et al.
Epilepsia Open|December 23, 2021
PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsyRobert T Wechsler, James Wheless, Muhammad Zafar, et al.
Epilepsia|December 20, 2022
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access programJerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, et al.
Epilepsy & Behavior : E&B|August 24, 2023
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension studyJames Wheless, Robert T Wechsler, Patricia Penovich, et al.
Epilepsia|July 2, 2019
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsyRobert T Wechsler, Rodney A Radtke, Michael Smith, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Seizure|June 21, 2020
Adjunctive perampanel and myoclonic and absence seizures: Post hoc analysis of data from study 332 in patients with idiopathic generalized epilepsyChristian Brandt, Robert T Wechsler, Terence J O'Brien, et al.
Epilepsia Open|April 21, 2022
Long-term open-label perampanel: Generalized tonic-clonic seizures in idiopathic generalized epilepsyJacqueline A French, Robert T Wechsler, Eugen Trinka, et al.
Epilepsia Open|July 15, 2024
Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complexRobert T Wechsler, David E Burdette, Barry E Gidal, et al.
Epilepsy Research|June 4, 2014
Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsyRobert T Wechsler, Robert Leroy, Anne Van Cott, et al.
Epilepsia|July 10, 2020
Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studiesIvan Rektor, Gregory L Krauss, Yushi Inoue, et al.
Epilepsia|September 2, 2016
Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizuresRobert C Sergott, Chris A Johnson, Kenneth D Laxer, et al.
Epilepsia Open|December 23, 2021
PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsyRobert T Wechsler, James Wheless, Muhammad Zafar, et al.
Epilepsia|December 20, 2022
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access programJerzy P Szaflarski, Orrin Devinsky, Merrick Lopez, et al.
Epilepsy & Behavior : E&B|August 24, 2023
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension studyJames Wheless, Robert T Wechsler, Patricia Penovich, et al.
Epilepsia|July 2, 2019
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsyRobert T Wechsler, Rodney A Radtke, Michael Smith, et al.
Pageof 3